Literature DB >> 15876978

Pathology and pathophysiology of vascular cognitive impairment. A critical update.

K A Jellinger1.   

Abstract

The prevalence, morphology, and pathogenesis of vascular dementia (VaD), recently termed vascular cognitive impairment (VCI), and of mixed dementia (Alzheimer disease associated with vascular encephalopathy) are a matter of discussion and clinical diagnostic criteria for these disorders slow low sensitivity and variable specificity. In Western memory clinic-based series, VaD/VCI is suggested in 8-10% of cognitively impaired elderly subjects. Its prevalence in autopsy series ranges from 0.03% to 58% with reasonable values of 4-10%. It has been related to focal, multifocal or diffuse cortical and/or subcortical microinfarcts and lacunes often affecting strategically important brain areas (thalamus, frontobasal and/or limbic systems), hemispheric white matter lesions and, less often, large brain infarcts. They result from systemic, cardiac or local large or small vessel disease. The pathogenesis of cerebrovascular lesions is multifactorial and their pathophysiology affects neuronal systems involved in cognition, memory, and behavior. Vascular pathology often coexists with Alzheimer disease (AD) and other dementing disorders; 25-60% of dementia cases show both AD and vascular lesions. The lesion patterns in ''pure'' VCI with predominant multiple small (subcortical) lesions related to arteriosclerosis and microangiopathies and in mixed dementia (AD associated with vascular encephalopathy), more often showing large infarcts, suggest different pathogenesis of both types of lesions. Due to the high variability of cerebrovascular pathology and its causative factors no validated neuropathological criteria exist for VCI and mixed dementia. In very old subjects selective hippocampal sclerosis may be associated with multiple other vascular pathologies. Minor cerebrovascular lesions, except for severe amyloid angiopathy, appear not essential for cognitive decline in full-blown AD, while both mild AD-type pathology and small vessel disease may interact synergistically in ''unmasking'' or promoting dementia. AD pathology is significantly less severe in the presence of cerebrovascular lesions. Further studies are needed to validate diagnostic criteria for VaD/VCI and to clarify the impact of vascular lesions on cognitive impairment as a basis for more precise clinical diagnosis, early prevention and management.

Entities:  

Mesh:

Year:  2004        PMID: 15876978

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  10 in total

Review 1.  Alzheimer 100--highlights in the history of Alzheimer research.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

2.  Schimke immuno-osseous dysplasia: a clinicopathological correlation.

Authors:  J Marietta Clewing; Barbara C Antalfy; Thomas Lücke; Behzad Najafian; Katja M Marwedel; Akira Hori; Ralph M Powel; A F Safo Do; Lydia Najera; Karen SantaCruz; M John Hicks; Dawna L Armstrong; Corndins F Boerkoel
Journal:  J Med Genet       Date:  2006-07-13       Impact factor: 6.318

Review 3.  Integrative Role of Hyperbaric Oxygen Therapy on Healthspan, Age-Related Vascular Cognitive Impairment, and Dementia.

Authors:  Priya Balasubramanian; Jordan Delfavero; Adam Nyul-Toth; Amber Tarantini; Rafal Gulej; Stefano Tarantini
Journal:  Front Aging       Date:  2021-09-23

4.  Auricular vagus somatosensory evoked potentials in vascular dementia.

Authors:  Thomas Polak; Falko Markulin; Ann-Christine Ehlis; Florian Metzger; Julia B Langer; Thomas M Ringel; Andreas J Fallgatter
Journal:  J Neural Transm (Vienna)       Date:  2009-03-11       Impact factor: 3.575

Review 5.  Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues.

Authors:  Chris Zarow; Traci E Sitzer; Helena C Chui
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

Review 6.  Cognition and chronic hypoxia in pulmonary diseases.

Authors:  Renata Areza-Fegyveres; Ronaldo A Kairalla; Carlos R R Carvalho; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2010 Jan-Mar

Review 7.  Animal Models of Chronic Cerebral Hypoperfusion: From Mouse to Primate.

Authors:  Kazuo Washida; Yorito Hattori; Masafumi Ihara
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

Review 8.  Vascular Dementia and Underlying Sex Differences.

Authors:  Firoz Akhter; Alicia Persaud; Younis Zaokari; Zhen Zhao; Donghui Zhu
Journal:  Front Aging Neurosci       Date:  2021-09-08       Impact factor: 5.750

9.  Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE).

Authors:  Penglian Wang; Yongjun Wang; Tao Feng; Xingquan Zhao; Yong Zhou; Yilong Wang; Weixiong Shi; Yi Ju
Journal:  BMC Neurol       Date:  2012-09-05       Impact factor: 2.474

Review 10.  Citicoline (Cognizin) in the treatment of cognitive impairment.

Authors:  Mario Fioravanti; Ann E Buckley
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.